Welcome to the new Gustave Roussy website
A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.
Villejuif, May 3rd, 2018
Death of Professor Thomas Tursz
The General Directorate and all Gustave Roussy's teams learned with an immense sorrow the death of Professor Thomas Tursz on April 27th, 2018 at the age of 71. Professor Tursz was an eminent oncologist and researcher. He directed Gustave Roussy over a period of 16 years. He made major contributions to the development of immunotherapy, cancer gene therapy and precision cancer medicine. He also had a significant input in the field of Epstein-Barr virus research, especially regarding virus recognition by the immune system and its oncogenic role.
“I shall make IGR a place of hope”, promised Professor Tursz when he became head of the Institute. His vision of how oncology patients should be treated was one of personalised medicine based on research led by multidisciplinary teams using advanced techniques and, above all, adapted to the individual patient.
He was General Director of Gustave Roussy from 1994 to 2010 and Honorary Director from 2010, Emeritus Professor of Oncology in the Paris-Sud University Medical Faculty and President of Unicancer from 2004 to 2010. He was born in Cracow in 1946 and led a distinguished career as a great physician and researcher. He was a pioneer in the use of novel therapeutic strategies in oncology, such as, for example, that of cytokine-based immunotherapy.
His work was recognised by the award of the highest distinctions in medicine and oncology. In 1988 he received the Academy of Sciences Oncology Prize and, in 1992, its Prize for Medicine. He received several prizes for his research work and a number of the most coveted European prizes, including the Hamilton Fairley Award for Clinical Research in 1998. He published more than three hundred scientific articles in leading international journals.
By training numerous students, he passed on his knowledge to a whole future generation of oncologists.
Professor Tursz was conscious of the need to inform the wider public, which he did through two books: “The Medical Revolution” in 2003 and “New Cancer Medicine, History and Hope” in 2013.
He thoroughly modernised Gustave Roussy, making it the leading European cancer centre. He was determined to invest in the long-term and, in particular, established a department devoted to supportive care and another to outpatient treatment, which both remain a reference point in the movement towards supportive care and ambulatory care becoming crucial in oncology.
He was awarded the honour of Officer of the Legion of Honour.
The General Directorate of Gustave Roussy acknowledges this great medical researcher with the highest respect and deep feelings. At this sad time, our thoughts are turned to his wife, son, family, friends and all those who knew him well at Gustave Roussy.
Thomas Tursz dedicated his life to other people's hope, health and wellness; and we deeply thank him for this and for showing us the way.
pr_professor-tursz-05-03-2018.pdf
Press contact
If you are a journalist and have a question, please contact:
Claire Parisel or Léona Pinto
Tel. +33 1 42 11 50 59
Tel. +33 1 42 11 63 59
Mob. +33 6 17 66 00 26
Email
The Media Team cannot respond to patient inquiries.
Last press releases
-
INTERCEPTION: The national pilot program for personalized cancer prevention among individuals at increased risk of cancer enters its operational phase with the enrollment of the first patients
The Interception program has reached a new milestone with the enrollment of its first patients as part of the national Article 51 pilot program. Rolled out over four years across seven healthcare facilities, this pilot program is designed to evaluate an innovative model for personalized cancer prevention and screening.
-
After a breast cancer diagnosis, how can treatment be started more quickly?
Gustave Roussy is launching a new care pathway designed to accelerate the management of women recently diagnosed with breast cancer. It brings together, in a single day, the radiology examinations, blood tests, and oncology consultation required to initiate treatment. This new pathway complements the Institute’s rapid breast care offering. The InstaDiag Breast pathway already consolidates all diagnostic examinations into a single day to establish a diagnosis.
-
Gold september: two new research programmes launched to tackle childhood cancers
Two of Gustave Roussy’s four new medical and scientific programmes are dedicated to childhood cancers. The first, DECRIPT, aims to improve understanding of the role played by genetics in the development of certain childhood cancers, as well as second cancers that may occur in adulthood. The second, INSPIRE, will draw on the knowledge and techniques already developed at the Institute to create organoids, with the aim of deciphering the mechanisms underlying metastasis and resistance to treatment.
-
Prof. Fabrice Barlesi reappointed at the head of Gustave Roussy, the leading cancer center in France and Europe
By order of Ms. Stéphanie Rist, Minister of Health, Families, Autonomy and Persons with Disabilities, dated 27 July 2026, Professor Fabrice Barlesi has been reappointed as Director General of Gustave Roussy, effective 1 August 2026. At the helm of the Institute for five more years, Prof. Barlesi will continue the transformations undertaken during his first term. This renewal reflects the confidence placed in the project led by the institution to accelerate progress in the fight against cancer, foster and support the development of innovations set to change the future of oncology, and strengthen the influence of one of the world's leading cancer centers.
